Skip to main content
INVAMED
HomeINVAblogMechanical Thrombectomy Devices in 2026: Aspiration, Rotational, and Stent-Retriever Landscape
Medical DevicesFebruary 22, 2026INVAMED Medical Affairs

Mechanical Thrombectomy Devices in 2026: Aspiration, Rotational, and Stent-Retriever Landscape

By INVAMED Medical Affairs, Clinical & Scientific Review BoardUpdated July 25, 2026

A clinical map of the 2026 mechanical thrombectomy device landscape: aspiration, rotational/pharmacomechanical, and stent-retriever platforms — how each class works, where it excels across stroke, DVT, PE, and dialysis access, and the selection criteria that drive first-pass success.

Mechanical thrombectomy devices fall into three functional classes — aspiration, rotational/pharmacomechanical, and stent-retriever platforms — and virtually every system on the 2026 market is a variation or hybrid of these mechanisms. Class selection is no longer brand loyalty: it follows clot age and composition, vessel size and fragility, embolization risk, and the increasingly explicit goal of single-session, lytic-sparing clearance. This review maps the mechanisms to the clinical beds — acute ischemic stroke, iliofemoral DVT, pulmonary embolism, peripheral arterial occlusion, and dialysis access — and summarizes the selection logic that drives first-pass success.

Class 1 — Aspiration: From Syringe to Smart Pump

Aspiration thrombectomy removes thrombus by suction through a catheter advanced to the clot face — manually with a syringe and locking valve, or via a dedicated vacuum pump with tubing and a collection canister. Its strengths are mechanical simplicity, no moving parts inside the vessel, and continuous visual feedback from the extracted material. Its limits are catheter bore (flow scales steeply with inner diameter), clot organization (chronic, fibrin-rich material resists suction), and blood loss if suction runs open without clot engagement. The design response across the field has been larger lumens, more trackable shafts, and smart suction control — cycling or modulating vacuum to reduce blood loss, a direction represented in INVAMED's portfolio by the VascuVac AI-assisted vacuum thrombectomy platform alongside the large-bore DOVI ultra-aspiration catheter. A technique-level comparison is covered in manual vs pump aspiration.

Class 2 — Rotational and Pharmacomechanical: Debulking Organized Clot

Rotational systems spin an element — basket, sinusoidal wire, or leaf-tip — that macerates thrombus while integrated aspiration evacuates the fragments; pharmacomechanical variants add locally delivered thrombolytic to soften fibrin-rich material during the same pass. This class earns its place where suction alone stalls: subacute and organized thrombus, long venous segments, and mixed-age clot burdens typical of iliofemoral DVT. INVAMED's Mantis family illustrates the design space: Mantis Pro for rotational maceration with ultra-aspiration, Mantis Leaf-Tip for wall-contact debulking, the over-the-wire Mantis Curve pharmacomechanical system for tortuous anatomy, and the Mantis XP configured for declotting dialysis fistulas and grafts, where wall-adherent, mixed-age thrombus is the norm. Mechanism details: rotational thrombectomy explained.

Class 3 — Stent Retrievers: The Neurovascular Workhorse

The stent retriever — a self-expanding mesh deployed through a microcatheter across the clot, engaged, and withdrawn — remains the defining device of stroke thrombectomy, alone or combined with local aspiration. Fragile intracranial vessels and zero tolerance for distal embolization shaped its design: gentle radial force, full-length clot integration, retrieval under flow arrest or aspiration. INVAMED's KinG intracranial revascularization device is the portfolio's stent-retriever-class platform; the stroke pathway, time windows, and combined techniques are reviewed in mechanical thrombectomy for stroke.

The Adjunct: Catheter-Directed Thrombolysis

Not every case needs — or tolerates — purely mechanical clearance. Catheter-directed thrombolysis infuses low-dose lytic directly into the thrombus over hours, and hybrid strategies pair a mechanical first pass with a short lytic tail for residual disease. Infusion platforms such as the INCA thrombolysis catheter with protection filter and the Viper Ultra thrombolysis catheter serve this role; the strategy comparison lives in CDT and EKOS for DVT and PE.

Mapping Device Class to Clinical Bed

Acute ischemic stroke: stent retriever, large-bore aspiration, or combined — speed and first-pass reperfusion dominate outcomes. Iliofemoral DVT: rotational/pharmacomechanical debulking for organized burden, large-bore aspiration for fresh clot; single-session clearance reduces post-thrombotic syndrome risk. Pulmonary embolism: large-bore aspiration is the growth segment for intermediate-high risk PE, with catheter-based PE treatment increasingly preferred over systemic lysis in bleeding-prone patients. Peripheral arterial occlusion: aspiration plus targeted lysis by clot age. Dialysis access: compact rotational systems built for wall-adherent thrombus and outflow-stenosis workflows.

Selection Criteria That Actually Decide the Case

Five variables recur in every device decision. Clot age: fresh red thrombus aspirates; organized white thrombus needs maceration or lytic softening. Vessel caliber and fragility: intracranial arteries take stent retrievers and gentle aspiration; iliac veins take large bores and rotation. Embolization control: protection filters, retrieval under aspiration, and wall-contact designs manage fragment escape — see preventing distal embolization. Blood loss budget: smart vacuum modulation and closed-loop aspiration matter in long venous cases. Bleeding risk: determines how much lytic, if any, the strategy can carry. The benchmark tying these together is the first-pass effect — complete or near-complete clearance in a single device pass, now a design goal across all three classes.

Where the Field Is Heading in 2026

Four visible trajectories: lytic-sparing, single-session workflows as the default ambition in venous disease; algorithmic aspiration control (clot-sensing vacuum cycling) to cut blood loss; bore escalation with trackability pushing large-lumen catheters deeper into tortuous anatomy; and procedure-specific configurations — dialysis-access, PE-dedicated, and below-knee variants replacing one-size-fits-all platforms. Purchasing teams evaluating platforms will find the procurement view in evaluating thrombectomy systems.

Frequently Asked Questions

What are the main types of mechanical thrombectomy devices?

Three classes: aspiration (suction through a catheter, manual or pump-driven), rotational/pharmacomechanical (spinning element macerates clot, with or without local lytic), and stent retrievers (self-expanding mesh that captures and withdraws the clot). Many procedures combine classes.

Which thrombectomy device class is best for DVT?

For fresh iliofemoral clot, large-bore aspiration; for organized or mixed-age burden, rotational/pharmacomechanical systems. The choice follows clot age on imaging and the goal of single-session clearance.

What is the first-pass effect and why does it matter?

Complete or near-complete clot clearance in one device pass. It correlates with better outcomes, shorter procedures, and fewer complications, and has become the primary performance benchmark across device classes.

Do mechanical thrombectomy devices eliminate the need for thrombolytics?

Increasingly often, yes — modern venous and PE workflows aim to be lytic-sparing. But hybrid strategies with low-dose catheter-directed lysis remain valuable for organized residual disease in patients who can tolerate it.

Related on INVAMED

Technique comparisons: aspiration vs rotational, stent retriever vs aspiration. Patient hubs: DVT, pulmonary embolism, stroke & neurovascular.


Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.

Reviewed by: INVAMED Medical Affairs

This content is prepared for educational purposes for healthcare professionals and does not constitute medical advice. Always consult clinical guidelines and product instructions for use.

mechanical thrombectomythrombectomy devicesaspiration thrombectomyrotational thrombectomystent retrieverpharmacomechanical thrombectomyfirst pass effectlarge bore aspirationvenous thrombectomy